Jane Street Group, LLC Sorrento Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$2.0 - $4.9 $1.3 Million - $3.18 Million	-649,200 Reduced 55.0%	531,100 $1.24 Million
Q4 2021 Feb 15, 2022	BUY	$4.65 - $7.23 $1.74 Million - $2.7 Million	373,300 Added 46.26%	1,180,300 $5.49 Million
Q3 2021 Nov 16, 2021	SELL	$7.41 - $10.99 $1.36 Million - $2.01 Million	-183,200 Reduced 18.5%	807,000 $6.16 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $2 Million - $3.15 Million	314,900 Added 46.63%	990,200 $9.6 Million
Q1 2021 May 18, 2021	SELL	$7.03 - $16.51 $4.74 Million - $11.1 Million	-674,300 Reduced 49.96%	675,300 $5.59 Million
Q4 2020 Feb 17, 2021	SELL	$5.76 - $11.95 $2.94 Million - $6.11 Million	-511,200 Reduced 27.47%	1,349,600 $9.21 Million
Q3 2020 Nov 17, 2020	BUY	$6.17 - $18.82 $5.04 Million - $15.4 Million	817,200 Added 78.31%	1,860,800 $20.7 Million
Q2 2020 Aug 17, 2020	BUY	$1.73 - $6.76 $1.76 Million - $6.89 Million	1,019,800 Added 4284.87%	1,043,600 $6.55 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $4.17 $34,510 - $99,246	23,800 New	23,800 $80,000
Q3 2018 Nov 14, 2018	SELL	$4.22 - $7.5 $46,420 - $82,500	-11,000 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$4.75 - $8.0 $52,250 - $88,000	11,000 New	11,000 $79,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.